L2 Asset Management, LLC Jazz Pharmaceuticals PLC Transaction History

L2 Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $739,235 - $853,967	-4,922 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$140.71 - $165.05 $92,868 - $108,933	-660 Reduced 11.82%	4,922 $812,000
Q3 2020 Nov 16, 2020	SELL	$105.46 - $144.13 $248,780 - $340,002	-2,359 Reduced 29.71%	5,582 $796,000
Q2 2020 Aug 13, 2020	SELL	$95.68 - $121.88 $130,029 - $165,634	-1,359 Reduced 14.61%	7,941 $876,000
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $170,215 - $296,315	-1,940 Reduced 17.26%	9,300 $928,000
Q4 2019 Feb 13, 2020	BUY	$117.65 - $153.73 $1.32 Million - $1.73 Million	11,240 New	11,240 $1.68 Million

500

57.4M

155K

152K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.98B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on L2 Asset Management, LLC with notifications on news.